TransMedics Group, Inc. (TMDX)
91.31
-0.07
(-0.08%)
USD |
NASDAQ |
Nov 16, 11:59
TransMedics Group EPS Diluted (Quarterly) : 0.4631 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.4631 |
| June 30, 2026 | 0.4057 |
| March 31, 2026 | 0.2021 |
| December 31, 2025 | 2.576 |
| September 30, 2025 | 0.6601 |
| June 30, 2025 | 0.9187 |
| March 31, 2025 | 0.7022 |
| December 31, 2024 | 0.1947 |
| September 30, 2024 | 0.1182 |
| June 30, 2024 | 0.3456 |
| March 31, 2024 | 0.3517 |
| December 31, 2023 | 0.1179 |
| September 30, 2023 | -0.7795 |
| June 30, 2023 | -0.0308 |
| March 31, 2023 | -0.0817 |
| December 31, 2022 | -0.2099 |
| September 30, 2022 | -0.2456 |
| June 30, 2022 | -0.4118 |
| March 31, 2022 | -0.3779 |
| December 31, 2021 | -0.4561 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.4679 |
| June 30, 2021 | -0.3862 |
| March 31, 2021 | -0.2893 |
| December 31, 2020 | -0.2323 |
| September 30, 2020 | -0.1874 |
| June 30, 2020 | -0.3642 |
| March 31, 2020 | -0.4171 |
| December 31, 2019 | -0.4335 |
| September 30, 2019 | -0.3918 |
| June 30, 2019 | -0.7001 |
| March 31, 2019 | -0.3269 |
| December 31, 2018 | -0.3827 |
| September 30, 2018 | -0.2559 |
| June 30, 2018 | -0.3063 |
| March 31, 2018 | -0.2458 |
| December 31, 2017 | -0.2329 |
| September 30, 2017 | -0.2409 |
| June 30, 2017 | -0.2879 |
| March 31, 2017 | -0.282 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4008 |
| Insulet Corp. | 2.030 |
| Abbott Laboratories | 0.5294 |
| Baxter International, Inc. | 0.5654 |
| Becton, Dickinson & Co. | 2.540 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.07M |
| Revenue (Quarterly) | 203.00M |
| Total Expenses (Quarterly) | 185.93M |
| Enterprise Value | 3.547B |
| Gross Profit Margin (Quarterly) | 56.20% |
| Profit Margin (Quarterly) | 8.41% |
| Earnings Yield | 3.99% |
| Operating Earnings Yield | 2.41% |
| Normalized Earnings Yield | 4.007 |